Improved survival using an intensive, pediatric-based chemotherapy regimen in adults with T-cell acute lymphoblastic leukemia

Murtadha Al-Khabori, Mark D. Minden, Karen W L Yee, Vikas Gupta, Aaron D. Schimmer, Andre C. Schuh, Wei Xu, Joseph M. Brandwein

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

All patients with newly diagnosed T-cell acute lymphoblastic leukemia (T-ALL) and treated over a 17-year period at a single institution were retrospectively analyzed. From 1990 to 2000, 40 patients were treated with a variety of adult-based ALL regimens. From 2000 to 2007, a pediatric-based protocol, DFCI (Dana Farber Cancer Institute), was used as the standard regimen for all patients (n=32). The two groups (DFCI and non-DFCI) had comparable baseline characteristics. Complete response rates were not significantly different between the DFCI- and non-DFCI-treated groups. The 3-year relapse free survival (RFS) and overall survival (OS) were significantly higher in the DFCI-treated group (p

Original languageEnglish
Pages (from-to)61-65
Number of pages5
JournalLeukemia and Lymphoma
Volume51
Issue number1
DOIs
Publication statusPublished - Jan 2010

Fingerprint

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Pediatrics
Drug Therapy
Survival
Neoplasms
Recurrence

Keywords

  • Acute lymphoblastic leukemia
  • Chemotherapeutic approaches
  • Prognostication

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Improved survival using an intensive, pediatric-based chemotherapy regimen in adults with T-cell acute lymphoblastic leukemia. / Al-Khabori, Murtadha; Minden, Mark D.; Yee, Karen W L; Gupta, Vikas; Schimmer, Aaron D.; Schuh, Andre C.; Xu, Wei; Brandwein, Joseph M.

In: Leukemia and Lymphoma, Vol. 51, No. 1, 01.2010, p. 61-65.

Research output: Contribution to journalArticle

Al-Khabori, Murtadha ; Minden, Mark D. ; Yee, Karen W L ; Gupta, Vikas ; Schimmer, Aaron D. ; Schuh, Andre C. ; Xu, Wei ; Brandwein, Joseph M. / Improved survival using an intensive, pediatric-based chemotherapy regimen in adults with T-cell acute lymphoblastic leukemia. In: Leukemia and Lymphoma. 2010 ; Vol. 51, No. 1. pp. 61-65.
@article{f9086100418e4c398fe17822152fa834,
title = "Improved survival using an intensive, pediatric-based chemotherapy regimen in adults with T-cell acute lymphoblastic leukemia",
abstract = "All patients with newly diagnosed T-cell acute lymphoblastic leukemia (T-ALL) and treated over a 17-year period at a single institution were retrospectively analyzed. From 1990 to 2000, 40 patients were treated with a variety of adult-based ALL regimens. From 2000 to 2007, a pediatric-based protocol, DFCI (Dana Farber Cancer Institute), was used as the standard regimen for all patients (n=32). The two groups (DFCI and non-DFCI) had comparable baseline characteristics. Complete response rates were not significantly different between the DFCI- and non-DFCI-treated groups. The 3-year relapse free survival (RFS) and overall survival (OS) were significantly higher in the DFCI-treated group (p",
keywords = "Acute lymphoblastic leukemia, Chemotherapeutic approaches, Prognostication",
author = "Murtadha Al-Khabori and Minden, {Mark D.} and Yee, {Karen W L} and Vikas Gupta and Schimmer, {Aaron D.} and Schuh, {Andre C.} and Wei Xu and Brandwein, {Joseph M.}",
year = "2010",
month = "1",
doi = "10.3109/10428190903388376",
language = "English",
volume = "51",
pages = "61--65",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Improved survival using an intensive, pediatric-based chemotherapy regimen in adults with T-cell acute lymphoblastic leukemia

AU - Al-Khabori, Murtadha

AU - Minden, Mark D.

AU - Yee, Karen W L

AU - Gupta, Vikas

AU - Schimmer, Aaron D.

AU - Schuh, Andre C.

AU - Xu, Wei

AU - Brandwein, Joseph M.

PY - 2010/1

Y1 - 2010/1

N2 - All patients with newly diagnosed T-cell acute lymphoblastic leukemia (T-ALL) and treated over a 17-year period at a single institution were retrospectively analyzed. From 1990 to 2000, 40 patients were treated with a variety of adult-based ALL regimens. From 2000 to 2007, a pediatric-based protocol, DFCI (Dana Farber Cancer Institute), was used as the standard regimen for all patients (n=32). The two groups (DFCI and non-DFCI) had comparable baseline characteristics. Complete response rates were not significantly different between the DFCI- and non-DFCI-treated groups. The 3-year relapse free survival (RFS) and overall survival (OS) were significantly higher in the DFCI-treated group (p

AB - All patients with newly diagnosed T-cell acute lymphoblastic leukemia (T-ALL) and treated over a 17-year period at a single institution were retrospectively analyzed. From 1990 to 2000, 40 patients were treated with a variety of adult-based ALL regimens. From 2000 to 2007, a pediatric-based protocol, DFCI (Dana Farber Cancer Institute), was used as the standard regimen for all patients (n=32). The two groups (DFCI and non-DFCI) had comparable baseline characteristics. Complete response rates were not significantly different between the DFCI- and non-DFCI-treated groups. The 3-year relapse free survival (RFS) and overall survival (OS) were significantly higher in the DFCI-treated group (p

KW - Acute lymphoblastic leukemia

KW - Chemotherapeutic approaches

KW - Prognostication

UR - http://www.scopus.com/inward/record.url?scp=74949134816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74949134816&partnerID=8YFLogxK

U2 - 10.3109/10428190903388376

DO - 10.3109/10428190903388376

M3 - Article

VL - 51

SP - 61

EP - 65

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 1

ER -